Trial · NCT07884851
Testing the Timing and Application of Virtual Reality Distraction During Knee Injections in a VA Pain Clinic
NCT07884851, Not applicable, Not yet recruiting, Atlanta VA Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Testing the Timing and Application of Virtual Reality Distraction During Knee Injections in a VA Pain Clinic. Trials, record NCT07884851. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07884851
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Testing the Timing and Application of Virtual Reality Distraction During Knee Injections in a VA Pain Clinic
- NCT number
- NCT07884851
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 45 participants, estimated
- Lead sponsor
- Atlanta VA Medical Center
- Conditions
- Pain Management, Injection Pain Prevention, Virtual Reality, Feasibility Studies, Distraction, Immersive Virtual Reality
- Interventions
- Immersive Virtual Reality
- First posted
- 2026-10-21
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Enrollment Rate | Throughout the enrollment period (approximately 8 weeks) | Proportion of eligible patients approached who provide written informed consent, calculated as the number consented divided by the number eligible and approached. Pre-specified feasibility benchmark: enrollment rate of 60% or greater. |
| Primary | Virtual Reality Setup Time | Day 1, from headset placement (after the pre-procedure timeout) to VR engagement, before needle insertion | Time in minutes from VR headset placement to participant engagement with the VR environment, recorded by stopwatch on the workflow timing log by the research coordinator. Assessed in the VR + standard of care arm only. |
| Primary | Virtual Reality Discontinuation Rate | Day 1, from headset placement through needle withdrawal | Proportion of VR + standard of care participants requiring headset removal before needle withdrawal and dressing application, with documented reason (participant request, observed distress or adverse reaction, or treating physician determination that the headset interferes with the procedure). Pre-specified feasibility benchmark: discontinuation rate below 10%. |
| Primary | Total Procedure Duration | Day 1, from signing of procedure consent to dressing application | Time in minutes from signing of the clinical consent for the knee injection to needle withdrawal and dressing application, recorded by stopwatch on the workflow timing log. Durations will be compared between arms to estimate time added by VR. Pre-specified feasibility benchmark: VR adds 5 minutes or less to total procedure duration. |
| Primary | Patient Satisfaction With the Procedure | Day 1, immediately following the procedure | Participant-rated overall satisfaction with the knee injection procedure on a 0-10 Numerical Rating Scale (0 = not satisfied, 10 = completely satisfied). Higher scores indicate greater satisfaction. Reported by arm. |
| Primary | Provider-Reported Workflow Disruption | Day 1, immediately following the procedure | Proportion of procedures in which the treating provider reports that the VR headset required modification to standard procedure steps (yes/no), with optional free-text description. |
| Primary | Provider-Reported Patient Comfort | Day 1, immediately following the procedure | Treating provider's rating of how comfortable the patient appeared during the procedure on a 0-10 Numerical Rating Scale (0 = not comfortable at all, 10 = extremely comfortable). Higher scores indicate greater perceived comfort. Reported by arm. |
| Primary | Willingness to Use Virtual Reality Again | Day 1, immediately following the procedure | Proportion of VR + standard of care participants answering "yes" to whether they would enjoy using VR in this procedure again. Pre-specified feasibility benchmark: 60% or greater. |
| Secondary | Procedural Pain Ratings | Day 1, immediately following the procedure | Three participant-rated items on 0-10 Numerical Rating Scales, each reported separately: (1) worst pain during the injection (0 = no pain at all, 10 = excruciating pain); (2) pain unpleasantness during the injection (0 = not unpleasant at all, 10 = excruciatingly unpleasant); (3) time spent thinking about pain during the injection (0 = none of the time, 10 = all of the time). Higher scores indicate worse outcomes on all three items. Reported by arm. |
| Secondary | Anxiety During the Procedure, Adjusted for Baseline | Baseline (Day 1, after consent and before randomization) and Day 1 immediately following the procedure | Participant-rated anxiety on a 0-10 Numerical Rating Scale (0 = not anxious or nervous at all, 10 = extremely anxious/nervous), measured at baseline (feeling prior to the injection) and post-procedure (feeling during the injection). Higher scores indicate greater anxiety. Procedural anxiety will be compared between arms with adjustment for baseline anxiety. |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07884851
GET https://conductscience.org/api/trials/v1/NCT07884851/registered